SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193805-13-001503
Filing Date
2013-08-20
Accepted
2013-08-20 16:31:02
Documents
10
Period of Report
2013-08-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 e611242_8k-retrophin.htm 8-K 50162
2 e611242_ex4-1.htm EX-4.1 105483
3 e611242_ex10-1.htm EX-10.1 259764
4 e611242_ex10-2.htm EX-10.2 166497
5 e611242_ex10-3.htm EX-10.3 22917
6 e611242_ex10-4.htm EX-10.4 45068
7 e611242_ex99-1.htm EX-99.1 9196
8 e611242_ex99-2.htm EX-99.2 7263
9 e611242_ex99-3.htm EX-99.3 12356
10 GRAPHIC logo.jpg GRAPHIC 2697
  Complete submission text file 0001193805-13-001503.txt   683835
Mailing Address 777 THIRD AVENUE 22ND FLOOR NEW YORK NY 10017
Business Address 777 THIRD AVENUE 22ND FLOOR NEW YORK NY 10017 212-983-1310
Retrophin, Inc. (Filer) CIK: 0001438533 (see all company filings)

IRS No.: 262383102 | State of Incorp.: OK | Fiscal Year End: 0229
Type: 8-K | Act: 34 | File No.: 000-53293 | Film No.: 131051074
SIC: 2834 Pharmaceutical Preparations